Monteron, Hernia C.

HRN: 00-17-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
CEFTRIAXONE 1G (VIAL)
12/03/2024
12/10/2024
IV
2g
OD
CAP MR; UTI
Waiting Final Action 
12/09/2024
MUPIROCIN 2%, 15G (TUBE)
12/09/2024
12/15/2024
TOPICAL
15g
Bid
Skin Lesion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: